Medivation Inc (MDVN) Soars On Pfizer Bid
Big pharma merger today and no it does not involve Valeant - those days are over - at least for now. Medivation Inc (NASDAQ: MDVN) is soaring around 20 percent as Pfizer Inc. (NYSE:PFE) has bid $14 billion for the company. The merger widely speculated over the weekend was announced this morning. So just how much synergies are we talking about? Here is what the sell side is saying.
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.